Clinical trial
Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
NCT03802058
Study timeline
Study start (actual)2019-03-20Date precision: day
Registry last updated2023-04-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Carcinoma, Non-Small-Cell Lungunresolved
Squamous Cell Carcinomaunresolved
Interventions
Nab-paclitaxelDRUG
CarboplatinDRUG · verified · RxNorm: carboplatin
Thoracic radiation therapyRADIATION
Sponsors & collaborators
Wuhan Universitylead sponsor
CSPC Ouyi Pharmaceutical Co., Ltd.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03802058 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.